The clinical complexity of patients with acromegaly.


Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
08 2022
Historique:
received: 18 10 2021
revised: 10 05 2022
accepted: 10 05 2022
pubmed: 2 6 2022
medline: 16 6 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

The main aim of the study was to investigate the factors related to the biopsychosocial complexity in the group of patients with acromegaly with different disease activity. A cross-sectional observational study was performed. First, a linguistic adaptation of the INTERMED - self-assessment questionnaire (IMSA) and after that the assessment of the biopsychosocial complexity among patients with acromegaly and the factors which relate to the complexity was made. The following tools were used to assess: biopsychosocial complexity: The INTERMED -self-assessment (IMSA); quality of life: The World Health Organization Quality of Life - BREF (WHOQoL) and Acromegaly Quality of Life questionnaire (AcroQol); mental state: The General Health Questionnaire - 28 (GHQ-28). The final analysis included 71 patients. According to the principal component analysis the mental state (GHQ-28) and the quality of life (AcroQol) are the most important factors related to the clinical complexity among patients with acromegaly. In the model created by a stepwise regression analysis for the total IMSA score higher growth hormone (GH) concentration, longer illness duration, and better general quality of life were included as the protective factors of the clinical complexity. By contrast, a high score in the severe depression subscale of GHQ-28 was a factor of higher clinical complexity. The mental state and quality of life are the most important determinants of the clinical complexity in the group of patients with acromegaly whereas the biochemical normalization is of lesser importance.

Identifiants

pubmed: 35644085
pii: S0022-3999(22)00231-8
doi: 10.1016/j.jpsychores.2022.110946
pii:
doi:

Substances chimiques

Human Growth Hormone 12629-01-5

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

110946

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Agnieszka Kobyłko (A)

Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: agnieszka.kobylko@student.umed.wroc.pl.

Dorota Szcześniak (D)

Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: dorota.szczesniak@umed.wroc.pl.

Jowita Halupczok-Żyła (J)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Dominik Marciniak (D)

Department of Dosage Form Technology, Wroclaw Medical University, 50-556 Wroclaw, Poland. Electronic address: dominik.marciniak@umed.wroc.pl.

Aleksandra Jawiarczyk-Przybyłowska (A)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Marek Bolanowski (M)

Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: marek.bolanowski@umed.wroc.pl.

Joanna Rymaszewska (J)

Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland. Electronic address: joanna.rymaszewska@umed.wroc.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH